AXIM® Biotechnologies Develops Novel Dual IgE/MMP-9 Rapid Ophthalmological Diagnostic Test; Files Provisional Patent
December 13, 2022 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Dec. 13, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company,...
Opthea Announce MST Access Hosted Conference Call with Professor Jason S. Slakter, MD
December 12, 2022 10:08 ET
|
Opthea Limited
MELBOURNE, Australia, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and...
Cataract Surgery Devices Market Size Worth USD 12.23 Billion by 2030 at 5.19% CAGR – Report by Market Research Future (MRFR)
December 12, 2022 09:30 ET
|
Market Research Future
New York, USA, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Cataract Surgery Devices Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Cataract Surgery Devices...
Sobi Receives Approval from Health Canada for Empaveli™ (pegcetacoplan) for the Treatment of Certain Patients with Paroxysmal Nocturnal Hemoglobinuria
December 09, 2022 11:00 ET
|
Sobi North America
The first targeted C3 therapy approved in CanadaApproval based on results from head-to-head PEGASUS phase 3 study where Empaveli™ demonstrated superiority to eculizumab in improving hemoglobin...
Atsena Therapeutics to Present at NewYorkBIO’s December 2022 Emerging Life Science Company Showcase
December 07, 2022 07:30 ET
|
Atsena Therapeutics
DURHAM, N.C., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent...
Iridex to Participate in Fireside Chat with Stifel Equity Research
December 06, 2022 17:07 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Radiation Dose Management Market Worth $749.1 Million by 2029 - Exclusive Report by Meticulous Research®
December 06, 2022 10:00 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Dec. 06, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, ‘Radiation Dose Management Market by Solution & Service, Modality (CT, Nuclear Medicine,...
AXIM Biotechnologies Commercial Partner Verséa Ophthalmics Highlights Benefits of AXIM’s Eye Diagnostic Solutions
December 06, 2022 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Dec. 06, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company,...
Fortress Biotech to Participate in Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference
December 06, 2022 08:30 ET
|
Fortress Biotech, Inc.
MIAMI, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and...
Journey Medical Corporation to Participate in Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference
December 05, 2022 16:05 ET
|
Journey Medical Corporation
SCOTTSDALE, Ariz., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that focuses on the...